Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-05-04
1979-03-27
Thomas, Jr., James O.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
560 16, 562426, 424319, C07C10384, A61K 31215, A61K 31195
Patent
active
041466390
ABSTRACT:
New carboxyalkylacylamino acids which have the general formula ##STR1## are useful as angiotensin converting enzyme inhibitors.
REFERENCES:
patent: 2569801 (1951-10-01), Cook
patent: 2940933 (1960-06-01), Jezl
patent: 3462535 (1969-08-01), Loev
patent: 3551419 (1970-12-01), Re
patent: 3852338 (1974-12-01), Kaiser
patent: 3896166 (1975-07-01), Kaiser
patent: 3950387 (1976-04-01), Joullie
patent: 4072703 (1978-02-01), Blum
Berse, J. Org. Chem., 27, pp. 3489-3495 (1962).
Vasilevskii, Zh. Org. Khimii, 2, pp. 244-249 (1970).
Cushman David W.
Ondetti Miguel A.
E. R. Squibb & Sons Inc.
Levinson Lawrence S.
Shippen Michael
Smith Merle J.
Thomas, Jr. James O.
LandOfFree
Carboxyalkylacylamino acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboxyalkylacylamino acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxyalkylacylamino acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1822133